SOUTHBOROUGH, MA – May 30, 2017 – Veristat, a full service Clinical Research Organization (CRO), congratulates TESARO, Inc. on the approval of ZEJULA™.
Veristat Acknowledged on Boston Business Journal’s “Fast 50” List for a Second Consecutive Year
May 15, 2017
Ranked as one of the Top 50 Fastest Growing Private Companies in Massachusetts
Veristat Appoints James Roach, MD as Chief Medical Officer
November 7, 2016
Veristat Strengthens its Clinical Operations, Medical and Regulatory Affairs Offerings
SOUTHBOROUGH, MA – November 07, 2016 – Veristat announced that it has appointed James (Jim) Roach, MD, FACP, FCCP as its new Chief Medical Officer to bolster the expansion of its clinical operations, medical and regulatory affairs offerings.
Veristat Formalizes its Strategic Decision Consulting Services
November 1, 2016
SOUTHBOROUGH, MA – November 01, 2016 – Veristat, a full service consultative Clinical Research Organization (CRO), announced today the formal launch of its Strategic Decision Consulting service offering to help pharmaceutical, biotechnology and medical device firms solve the unique and complex challenges they face throughout the development process.